Clinical Trials in Chicago

Showing 6101-6120 of 20,493 trials

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

NCT04634799

This is a single-center, randomized double blind placebo controlled trial to evaluate the efficacy and safety of novel PAI-1 inhibitor (TM5614) for high-risk patients hospitalized with severe COVID-19 at Northwestern Memorial Hospital. The patients will be randomized in a 1:1 ratio to receive standard of care plus TM5614 or standard of care plus placebo.

Covid19

Northwestern University9 participantsStarted Jan 2021

Chicago, Illinois, United States

Active Not RecruitingNA2.2 miles

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

NCT04089059

This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).

Heart Failure NYHA Class III

Endotronix, Inc.738 participantsStarted Jan 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Phoenix, Arizona, United States +71 more locations

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Find Trials by Condition in Chicago

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

African-American Social Support Effectiveness Treatment

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

A Phase 2b Study of Icosabutate in Fatty Liver Disease

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Moving Forward Together 2.0: An Activity Intervention

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Cardiovascular Risk Screening and Risk Reduction in Women Vets